|
Market Closed -
Nasdaq
04:00:00 2026-10-06 pm EDT
|
5-day change | 1st Jan Change | ||
| 402.60 USD | -0.09% |
|
-4.97% | +23.00% |
| Oct. 02 | AbbVie joins US government pilot to test drug discount rebates | RE |
| Sep. 30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 218B 193B 181B 164B 310B 20,982B 312B 2,172B 845B 10,704B 817B 799B 34,410B | P/E 2026 * |
25.4x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 259B 230B 215B 195B 369B 24,982B 371B 2,586B 1,006B 12,744B 973B 952B 40,970B | EV / Sales 2026 * |
6.65x | EV / Sales 2027 * | 6.29x |
| Free-Float |
99.77% | Yield 2026 * |
2.51% | Yield 2027 * | 2.65% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Tradegate
| AMG | Real-time | |
|
Boerse Muenchen
| AMG | Real-time | |
|
London S.E.
| 0R0T | Delayed | |
|
CBOE
| 0R0T | Real-time | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
CBOE
| Real-time | ||
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote |
Last Transcript: Amgen Inc.
| 1 day | -0.09% | ||
| 1 week | -4.97% | ||
| Current month | -4.49% | ||
| 1 month | -7.92% | ||
| 3 months | +9.87% | ||
| 6 months | +17.52% | ||
| Current year | +23.00% |
| 1 week | 396.01 |  | 422.8 |
| 1 month | 374.46 | | 426.59 |
| Current year | 318.21 | | 447.03 |
| 1 year | 288 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 8/13/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 8/7/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -4.97% | +36.88% | +50.52% | 218B | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,032B | |
| +0.73% | -4.78% | +35.41% | +61.62% | 614B | |
| +0.35% | +1.29% | +15.86% | +79.90% | 471B | |
| +1.72% | -4.92% | +59.84% | +36.64% | 350B | |
| +0.26% | +0.14% | +21.29% | +40.99% | 337B | |
| +0.60% | -3.09% | +10.76% | +32.59% | 268B | |
| +1.65% | -3.78% | -6.03% | +9.29% | 246B | |
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | |
| -0.51% | -2.42% | -36.48% | -61.95% | 164B | |
| Average | +0.29% | -3.56% | +20.15% | +44.74% | 387.85B | |
| Weighted average by Cap. | +0.03% | -3.38% | +26.75% | +61.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 34.57B 32.35B 29.32B 55.38B 3,754B 55.78B 389B 151B 1,915B 146B 143B 6,157B | 40.32B 35.79B 33.49B 30.36B 57.33B 3,887B 57.75B 402B 156B 1,983B 151B 148B 6,374B |
| Net income | 8.58B 7.62B 7.13B 6.46B 12.2B 827B 12.29B 85.61B 33.3B 422B 32.21B 31.52B 1,357B | 9.39B 8.34B 7.8B 7.07B 13.36B 905B 13.45B 93.72B 36.45B 462B 35.26B 34.5B 1,485B |
| Net Debt | 41.5B 36.84B 34.47B 31.24B 59.01B 4,000B 59.43B 414B 161B 2,041B 156B 152B 6,560B | 35.77B 31.76B 29.72B 26.94B 50.87B 3,449B 51.24B 357B 139B 1,759B 134B 131B 5,656B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-06 | $402.60 | -0.09% | 2,036,870 |
| 26-10-05 | $402.98 | -0.01% | 3,104,125 |
| 26-10-02 | $403.04 | -1.04% | 3,510,312 |
| 26-10-01 | $407.27 | -3.38% | 2,501,030 |
| 26-09-30 | $421.51 | -0.50% | 3,130,965 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
